Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder

Pathobiology

Volumn 75, Issue 6, 2008, Pages 335-345

  Chikazawa, M ^a   Inoue, K ^a   Fukata, S ^a   Karashima, T ^a   Shuin, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; Metastasis; Transitional cell carcinoma; Tumor progression; Urothelial cell carcinoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CARCINOGENIC ACTIVITY; CELL STRAIN 253J B V; CLONE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TUMOR GROWTH; UROTHELIAL CELL CARCINOMA;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS MUSCULUS;

EID: 58149096963     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000164218     Document Type: Article

References (25)

1. Ravery V, Jouanneau J, Gil Diez S, Abbou CC, Caruelle JP, Barritault D, Chopin DK: Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res 1992;20:211-214.
2. Allen LE, Maher PA: Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol 1992;155:368-375.
3. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-1262.
4. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510-513.
5. Tachibana M, Miyakawa A, Nakashima J, Murai M, Nakamura K, Kubo A, Hata JI: Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. Br J Cancer 1997;76:163-174.
6. Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 2000;15:2290-2299.
7. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167:1883-1893.
8. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL: Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994;74:762-766.
9. Dinney CP, Babkowski RC, Antelo M, Perrotte P, Liebert M, Zhang HZ, Palmer J, Veltri RW, Katz RL, Grossman HB: Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 1998;160:1285-1290.
10. Inoue K, Slaton JW, Karashima T, Yoshikawa C, Shuin T, Sweeney P, Millikan R, Dinney CP: The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 2000;6:4866-4873.
11. Dinney CP, Fishbeck R, Singh RK, Eve B, Pathak S, Brown N, Xie B, Fan D, Bucana CD, Fidler IJ, Killion JJ: Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 1995;154:1532-1538.
12. Wei Q, Guan Y, Cheng L, Radinsky R, Bar EM, Tsan R, Li L, Legerski RJ: Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction. Pathobiology 1997;65:293-300.
13. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M: Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 1988;331:173-175.
14. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-220.
15. Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E, Fidler IJ: In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am J Pathol 1995;147:1238-1247.
16. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary KR, Brigati DJ, Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 1993;53:937-943.
17. Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ, Fidler IJ: A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J Histochem Cytochem 1993;41:499-506.
18. Reed JA, Manahan LJ, Park CS, Brigati DJ: Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992;13:434-443.
19. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, Dejana E: Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 1994;63:247-254.
20. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
21. Kumar R, Kuniyasu H, Bucana CD, Wilson MR, Fidler IJ: Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res 1998;10:301-311.
22. Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP: Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 2001;8:9-15.
23. Inoue K, Perrotte P, Wood CG, Slaton JW, Sweeney P, Dinney CP: Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor. Clin Cancer Res 2000;6:4422-4431.
24. Inoue K, Chikazawa M, Fukata S, Yoshikawa C, Shuin T: Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Clin Cancer Res 2002;8:2389-2398.
25. Inoue K, Wood CG, Slaton JW, Karashima T, Sweeney P, Dinney CP: Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8. Oncol Rep 2001;8:955-964.